666 results on '"Imai, Masaki"'
Search Results
52. NS1 is the fluid for “flu-transmission”
53. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques
54. Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging
55. The trajectory of non‐depressed suicidal ideation in community‐dwelling older people in a rural area in Japan: a prospective longitudinal study with a 3‐year follow‐up
56. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir
57. Design and synthesis of a second-generation ligand-tethered calcium indicator for plant cell biology based on the fundamental analyses of the structure and physical property
58. Characterization of a Feline Influenza A(H7N2) Virus
59. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo
60. Peritoneal Expression of Membrane Complement Regulators Is Decreased in Peritoneal Dialysis Patients with Infected Peritonitis
61. Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
62. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
63. Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection
64. Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
65. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
66. SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters
67. BASIC STUDY ON ESTIMATION OF RESIDUAL CHLORINE CONCENTRATION REDUCTION IN GRAVITY TANK
68. Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
69. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals
70. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
71. A Novel Rhabdovirus Detected in Anisakis Larvae Distributed in the Coastal Areas of Japan: Viral Genome Analysis and Possible Coevolutionary Relationship between Virus and Host
72. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
73. Magnetic Phases in Sr1-x CaxCo2P2 Studied by μ+ SR
74. Substitution Effects in the Itinerant Electron Metamagnetic Compound SrCo2P2
75. Host-Selective Phytotoxins Incorporating the Epoxy-Triene-Decacarboxylate Moiety Function through the Hijacking of the Plant–Microbe Interaction System
76. Long-term peritoneal dialysate exposure modulates expression of membrane complement regulators in human peritoneal mesothelial cells
77. In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
78. Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
79. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
80. Temperature-variable apparatus for measuring Barnett field.
81. Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air
82. Can SARS-CoV-2 transmit from a dead body?
83. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
84. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
85. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
86. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates
87. Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.
88. Mutations at the monomer–monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs
89. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
90. Pressure driven magnetic order in Sr1-xCaxCo2P2
91. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
92. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals
93. Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model
94. Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
95. Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children
96. Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine
97. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
98. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
99. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
100. Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.